A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings from the ATTAIN-2 trial led by a UTHealth Houston researcher
NINA MOINI: What else do you think doctors consider when they're prescribing GLP-1s to seniors
The relationship between the microbiome and sleep matters here because circadian rhythm disruption can affect appetite timing, microbial rhythms, SCFA production, and metabolic regulation
SURMOUNT-1 subgroup data from 2,542 women showed tirzepatide produced ~23% body weight reduction in peri/postmenopausal women vs 3% on placebo
The FDA Right now, there isnt any data on the amount of semaglutide that passes into human breast milk, how it might affect babies, and how it might impact milk production
MC4R variants, FTO polymorphisms, and ASIP genes influence baseline melanin production and response to depigmenting agents